CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 79 enrolled
Drug / intervention
Parathyroid Eye (PTeye)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05152927
NCT05152927N/ACompleted

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

University of California, San Francisco·interventional·Posted Dec 10, 2021·Updated Dec 15, 2025

In Brief

A clinical study evaluating Parathyroid Eye (PTeye) for Parathyroid Diseases and 9 related conditions. Completed, enrolled 79 participants across 1 site.

Detailed Summary

The goal of this study is to assess whether using PTeye (AiBiomed, Santa Barbara, CA) - a NIRAF detection modality - can improve patient outcomes and reduce healthcare associated costs after parathyroid surgeries. By being able to quickly and definitively locate parathyroid glands while in the operating room, the duration of surgical procedure could be further reduced. In addition, the number of frozen section biopsy and associated costs can be minimized. Furthermore, repeat surgeries as a result of missing a diseased parathyroid gland at the time of the initial parathyroidectomy for hyperparathyroidism could potentially be avoided.

Study Details

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 10, 2021
Enrollment StartJan 10, 2022
Primary CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.6 years ago

Interventions

Parathyroid Eye (PTeye)device

Intraoperative Tool